Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Sinovac Biotech, Ltd./ 20-F

SEC Filing · 20-F

Sinovac Biotech, Ltd.

SVANASDAQEQUITYCurrent

SEC Filing

Filed Apr 30, 2026Accepted Apr 30, 2026, 9:17 AM EDTCIK 1084201Accession 0001193125-26-194394
View company →Permanent SEC source ↗
Share

Company context

Current securities

SVANASDAQ · EQUITY · Current

Recent company filings

  1. 6-K filingAug 17, 2026
  2. 6-K filingJul 15, 2026
  3. 6-K filingJun 15, 2026
  4. 6-K filingJun 5, 2026
  5. 20-F filingJun 5, 2026

As-filed source

Primary evidence
As filedOpen full document ↗